Top stories
Pfizer Inc. has announced new data on PRISTIQ, or desvenlafaxine, extended release tablets 50mg/day for the treatment of major depressive disorder, or MDD, in adults, including a long-term relapse prevention study...more >>
Dover Saddlery, Inc., a multi-channel retailer of equestrian products, has reported that net income for the first quarter ended March 31, 2012 was $221,000, or $0.04 per diluted share, compared to $125,000, or $0.02 per diluted share, for the first quarter ended March 31, 2011...more >>
Suzuki Motor Corporation has reported the net income of JPY53.89 billion, or JPY88.28 per diluted share, an increase of 19.3%, for the year ended March 31, 2012, compared to JPY45.17 billion, or JPY74.11 per diluted share, for the year ended March 31, 2011...more >>
Vical Incorporated, which researches and develops biopharmaceutical products based on its deoxyribonucleic acid DNA delivery technologies for the prevention and treatment of life-threatening diseases, has reported that net income for the first quarter ended March 31, 2012 was $244,000, or $0 per share, compared to a net loss of $8.69 million, or $0.12 loss per share, for the first quarter ended March 31, 2011...more >>